The chromosomal location of the human dihydrofolate reductase (DHFR; EC 1.5.1.3) gene that is amplified in a methotrexate-resistant human cell line has been investigated by screening a large number of human-mouse cell hybrids containing overlapping subsets of human chromosomes.
signment of the human DHFR gene to chromosome 5. This chromosome assignment has been confirmed by the observation of a concomitant loss of the human DHFR gene and of sensitivity to diphtheria toxin, a marker associated with chromosome 5, in two human-mouse cell hybrids selected for resistance to the toxin. Six EcoRI fragments of human DNA containing DHFR pseudogenes or other DHFR-related sequences have been assigned to chromosomes other than chromosome 5. Recently, several cell variants resistant to high concentrations of the folate antagonist methotrexate (MTX) have been isolated from two different human cell lines, HeLa BU25 and VA2-B (1). As described for other mammalian culture systems (2) , these cell lines overproduce dihydrofolate reductase (DHFR; 5,6,7,8-tetrahydrofolate:NADP+ oxidoreductase, EC 1.5.1.3), the target enzyme of MTX (1) , as a consequence of selective amplification of the structural gene for DHFR (3) . A striking feature of these MTX-resistant human cell variants is the pleomorphism of chromosomal alterations they exhibit. These include a highly variable number of double-minute chromosomes (DMs) (1), a homogeneously staining region (HSR) in one or more marker chromosomes, and a duplicated set of chromosomes in most cells of some variants (1) . To understand the nature and origin of these chromosomal anomalies, the normal chromosomal location of the DHFR structural gene must be defined, since, in rodent cells (2) and human cells (unpublished data), both DMs and HSRs have been shown to be the sites of amplified DHFR genes. The recent cloning and characterization of human DHFR cDNAs (4) and the identification of the amplified DHFR structural gene fragments in EcoRI digests of genomic DNA (3) make it possible to study the segregation of the human DHFR gene in human-mouse hybrid cells containing overlapping subsets of human chromosomes and, by this approach, to identify the chromosome in normal human cells that is the site of the DHFR gene. In this study, the human DHFR gene is assigned to chromosome 5, and six EcoRI fragments containing DHFR pseudogenes or other DHFR-related sequences are shown to be located in human chromosomes other than 5. Mg/ml. The parents of the hybrid cell lines of the AHA series were mouse A9 and human GM144; those of the 41pT series and of the FRY series, mouse A9 and human GM126; and those of the BDA series, mouse A9 and human GM589. The human cell lines GM144 and GM126 are two fibroblast lines with balanced chromosome translocations not involving chromosome 5, and the cell line GM589 is a fibroblast line with a balanced translocation of almost the entire chromosome 5 onto the long arm of chromosome 14 (Human Genetic Mutant Cell Repository, Camden, NJ, 1982). Nine independent hybrid clones, five subclones isolated from them by dilution plating, and two diphtheria toxin-resistant sublines derived from two independent clones were analyzed. The hybrids were grown as described (5) .
MATERIALS AND METHODS

Materials
DNA Extraction. High molecular weight DNA from VA2-B, HeLa S3, and A9 cells was prepared by the method of Gross-Bellard et al. (6) . Cell hybrid DNAs were prepared as reported (5) , additionally digested with RNase and Pronase, extracted with phenol, precipitated with ethanol, and suspended in 10 mM Tris-HCl/1 mM EDTA, pH 8.0.
Preparation of Radioactive Probes. Nick-translation of the insert fragment of pHD84 (4), of the "probe 1.7," a derivative of pAT153 containing a 1.14-kilobase (kb) chromosome 5-specific single-copy DNA fragment (provided by P. Pearson), was carried out as described (4), using DNase I at 25 pg/ml, 4 20 AsM, to give a specific activity of 4-8 x 108 cpm/,ug. The BamHI fragments e andf of the c-fms human oncogene (7), which is located on human chromosome 5 (7, 8) , were nick-translated by a similar procedure.
DNA Transfer and Hybridization Techniques. DNA samples (amounts specified in figure legends) were digested to completion with an excess of EcoRI restriction enzyme, electrophoresed through a 0.7% agarose slab gel, and transferred to nitrocellulose filters by the method of Southern (9) .
Abbreviations: MTX, methotrexate; DHFR, dihydrofolate reductase; DM, double-minute chromosome; HSR, homogeneously staining region; kb, kilobase(s).
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Hybridization with the 32P-labeled probe was carried out as described (3), except for the absence of poly(cytidylic acid), using 1.5-2.0 x 107 cpm of probe per filter in 5 ml of hybridization buffer. The filters were washed at 680C once with 6x NaClI/Cit (lx NaClI/Cit = 0.15 M NaCl/0.015 M sodium citrate)/10x Denhardt's solution (10)/0.1% sodium pyrophosphate/0.1% NaDodSO4 for 30 min, three times with 2x NaClICit/0. 1% NaDodSO4, and three times with 0.5 x NaCl/ Cit/0. 1% NaDodSO4, 20 min each. The filters were then dried and exposed for autoradiography (4) .
Isozyme and Karyotype Analysis. All clones and subclones were subjected to isozyme analysis and most were karyotyped; furthermore, the DNA from the majority of the hybrids was also tested with chromosome 5-specific probes (BamHI fragments e and f of the c-fms human oncogene and "probe 1.7") and with a chromosome 12-specific probe (5). The isozyme tests were previously described (5) . The chromosome constitution of the hybrids was determined on Giemsa-banded metaphases per hybrid. The following criteria were used for characterization of the cell hybrid lines: A cell line was scored positive (+) for a human chromosome when its presence was revealed by appropriate isozyme expression and by karyotypic identification in >20% of metaphases; in some cases, a clear karyotypic identification alone or isozyme expression in the absence of karyotype data was used for positive chromosome scoring. When no isozyme markers were expressed and when, in the karyotyped hybrids, <5% of cells exhibited the specific human chromosome, the hybrid was scored negative (-). In the case of chromosome 5, the results of the specific probe hybridization assays were also used as criteria, and they were always found to be in agreement with the other scoring criteria, so that all scorings for chromosome 5 were based on at least two criteria. A hybrid was scored as weakly positive (+/-) when the chromosome was present in 5-20% of metaphases and the isozyme analysis gave inconsistent results in multiple assays. In cases in which the isozyme and karyotype data were insufficient to clearly characterize a hybrid, this was scored 0 and the corresponding data were not included in the mapping summary. In the hybrids of the series BDA deriving from A9 and the human fibroblast line GM589 that were positive for chromosome 5 by karyotypic analysis, both translocated and nontranslocated chromosomes 5 were observed and scored. In three of these hybrids (10a3-1, 10a3-4, and 10a3-6), the translocated chromosomes 5 were predominant (83-100%), in two other hybrids (17b17 and 10a4aFa9_1), mostly nontranslocated chromosomes 5 were observed (79% and 63%, respectively).
RESULTS
Organization of DHFR-Specific Sequences in Genomic
DNAs from Human and Mouse Cells. The plasmid pHD84 is a human DHFR cDNA clone derived from the MTX-resistant VA2-B derivative 6A3 and contains the complete human DHFR-encoding sequence (3, 4) . The coding sequence of human DHFR shows an 89% nucleotide sequence homology to that of the mouse (11). The plasmid pHD84 was used to screen human-mouse somatic cell hybrid DNAs for human DHFR-specific sequences. Southern blots of EcoRI-digested human genomic DNA probed with pHD84 show a complex pattern consisting of fragments of the human DHFR gene that is amplified in VA2-B 6A3 cells and of fragments containing other DHFR-specific sequences (3) . Two of the latter fragments have been shown to contain portions of an intronless pseudogene (3), while the nature of the other DHFR-related sequences is uncertain. In this paper, fragments that hybridize to the DHFR pHD84 probe, but that do not belong to the structural gene amplified in 6A3 cells, will be referred to as DHFR-related sequences. . The fragments of the structural gene amplified in VA2-B DNA, which correspond to those amplified in the DNA from the MTX-resistant VA2-B 6A3 cell line (3), are 13, 6, 4, 1.8, and 1.6 kb in size. These fragments, which span the entire reading frame for human DHFR, have recently been shown to be a part of the human structural gene for DHFR by molecular cloning and DNA sequence analysis (12) . The 1.6-, 4-, and 13-kb EcoRI fragments have been cloned, and the organization of this portion of the gene has been determined (13) . Fragments not associated with the structural gene are designated in Fig. 1 by letters a-g and have molecular sizes of 18, 17, 3.8, 3.5, 2.3, 2, and -1.6 kb, respectively (ref. 4 and present work). The two fragments d and e contain the recently isolated intronless pseudogene (3) mentioned above.
The hybridization pattern of an EcoRI digest of mouse A9 cell DNA probed with the human DHFR probe pHD84 is shown in lane 4 of Fig. 1 . The four expected EcoRI fragments of the mouse DHFR gene can be seen (14) , as indicated by long arrows. In addition, two previously unreported mouse DNA fragments containing DHFR-related sequences are detected by the human DHFR probe, as shown by short arrows. The fragments of the human DHFR gene with sizes of 13, 6, and 4 kb migrate to positions in the gel that correspond closely to those of mouse DNA fragments hybridizing with the DHFR probe. In contrast, the 1.8-and 1.6-kb gene fragments are found in regions of the blot free of mouse-specific bands. Thus, it has been possible to score the humanmouse hybrid DNAs for the human DHFR gene by using the 1.8-and 1.6-kb bands as diagnostic of the entire gene. How- ever, bands corresponding to the other expected human DHFR gene fragments were always observed whenever the 1.8-and 1.6-kb bands were present. Furthermore, in several cases, from the intensity of the signal given by these other bands (in particular the 13-and 6-kb bands) and/or the absence of expected mouse gene fragments, the association of these bands with human gene fragments could be inferred.
One also sees in Fig. 1 that the human DNA fragments contalning DHFR-related sequences a, b, c, e, f, and g are not obscured by cross-hybridizing mouse DNA fragments. digested with EcoRI were treated as described for Fig. 1 Correlation of Human DHFR Structural Gene, Chromosome 5 Markers, and Diphtheria Toxin Sensitivity in HumanMouse Cell Hybrids. The assignment of the human DHFR gene to chromosome 5 indicated by the mapping experiments discussed above suggested a confirmatory experiment based upon the selectable loss of a marker previously mapped in human chromosome 5. It has been shown that sensitivity to diphtheria toxin in human-mouse cell hybrids is associated with a gene or genes located in human chromosome 5 (15) . Therefore, human-mouse cell hybrids can be selected for the loss of human chromosome 5 by growing them in the presence of diphtheria toxin. Two human-mouse cell hybrids containing the human DHFR gene were exposed to Connaught diphtheria toxin at 2 x 10' Lf units/ml (15) , and a toxin-resistant subline was isolated from each. The four lines were subjected to isozyme and karyotype analysis (Table 1) ; in particular, they were screened for expression of hexosaminidase B, a human chromosome 5 marker (16), and further tested for the presence of chromosome 5 by probing genomic blots with a human chromosome 5 unique sequence DNA marker (probe 1.7). By both criteria, the two cell lines had retained human chromosome 5 while the two diphtheria toxin-resistant derivatives had lost this chromosome. It should be noticed that chromosome 5 was the only chromosome lost by both toxin-resistant sublines. The DNAs from the four lines were then screened for the human DHFR structural gene. Fig. 4 shows the results of the blotting experiment utilizing the human DHFR probe (Fig. 4A, lanes 2-4) or the chromosome 5-specific probe 1.7 (Fig. 4B, lanes 8-11) . The absence of the 1.8-and 1.6-kb human DHFR bands from the DNA blots of the diphtheria toxin-resistant lines indicates that the human DHFR gene has been lost. Thus, the loss of chromosome 5 in the diphtheria toxin-resistant lines is accompanied by the loss of the human DHFR gene. This result strongly supports the assignment of the human DHFR gene to chromosome 5.
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Polymorphism of the probe 1.7 in human populations has been reported (17) . This is reflected in the appearance of additional probe 1.7-related bands in HeLa cell DNA (Fig. 4B , lane 7) and in the DNA from the cell hybrid BDA 17b17-1 (Fig. 4B, lane 10) .
DISCUSSION
The distribution of the human DHFR gene in all the hybrid cell lines analyzed, including the diphtheria toxin-resistant derivatives, is summarized in Table 2 . It is clear that chromosome 5 is the only chromosome showing a complete concordance of segregation with the DHFR gene. Other genomic blotting data (not shown) have revealed the absence of the DHFR gene in six additional human-mouse cell hybrids lacking chromosome 5 . We conclude that the DHFR structural gene that has been amplified in the human cell lines VA2-B and VA2-B 6A3 resides in human chromosome 5.
The present analysis has also provided information concerning the chromosomal location of several fragments containing human DHFR-related sequences. Only the unambiguous data of allow an unambiguous chromosome assignment for these fragments, they do exclude most chromosomes, including chromosome 5, as their sites. Two of these fragments, d and e (Fig. 1) , have recently been shown to contain an intronless DHFR pseudogene, qiHDI (3) . On the basis of the data reported here, an assignment of the pseudogene u/HDJ to chromosome 3 or X has been made, with the evidence strongly favoring chromosome 3. Two other fragments, b and c ( Fig.  1) , because of their size and the intensity of the hybridization signal, appear to be good candidates for containing two additional intronless DHFR pseudogenes that have recently been isolated from human DNA libraries (13) . In particular, fragment b has a size (-17 kb) that is compatible with the >15-kb EcoRI subfragment carrying the hDHFR-qi2 pseudogene isolated from a fetal DNA library, and fragment c has a size (-3.8 kb) very close to that of the fragment containing the hDHFR-Vl pseudogene isolated from an adult DNA library.
The present analysis indicates that fragment b is located in chromosome 2 or 6, while fragment c is located in chromosome 3 or X. The nature of the other fragments producing faint bands in the EcoRI restriction pattern of DHFR-specific sequences in human genomic DNA (fragments a, f, and g, Fig. 1 ) is unknown. The low intensity of the signals given by these fragments with a DHFR cDNA probe and the chromosome segregation pattern would exclude the possibility that they represent DHFR genes with different EcoRI restriction patterns.
The present chromosome assignment of the human DHFR gene is relevant to the origin of the chromosomal anomalies, DMs and HSRs, observed in several MTX-resistant cell lines (1, 18, 19) . The human MTX-resistant cell line VA2-B 6A3 exhibits an HSR containing amplified DHFR genes in the long arm of a chromosome clearly distinct from chromosome 5 (unpublished data). HSRs observed in other human MTXresistant cell lines have been reported to be located in chromosomes 6, 19 (ref. 18) , and 10 (ref. 19 ). The observation in human MTX-resistant cell lines of HSRs containing amplified DHFR genes in chromosomes other than chromosome 5 strongly suggests that a translocation event from chromosome 5 to other chromosomes has occurred in these cell lines. A role for DMs in the amplification and translocation of the DHFR gene has been suggested (2, 20) , but very little evidence has been reported about their possible involvement. Recently, an apparent translocation and amplification of the c-myc gene from its normal position in human chromosome 8 to HSRs in the X chromosome has been described in malignant neuroendocrine cells derived from a human colon carcinoma (21) . In the present case, an interesting possibility is suggested by the observation that the human genome contains, besides the DHFR structural gene that is amplified in 6A3 cells, up to as many as six other loci showing homology to the human DHFR probe. It is conceivable that translocation events involving homologous recombination between the DHFR structural gene in chromosome 5 and other DHFR-related sequences located elsewhere in the genome are responsible for the formation of at least some of the HSRs observed in MTX-resistant cell lines. Finally, the chromosomal linkage between the DHFR gene and the gene(s) conferring diphtheria toxin sensitivity to human cells parallels the demonstrated presence of these two loci in chromosome 2 of Chinese hamster cells (22) (23) (24) . It should also be mentioned that three other genes, leuS, emtB, and chr, are linked to the DHFR gene in both human chromosome 5 and Chinese hamster chromosome 2 (25) . Considering the distance between these loci, the above observations provide a striking example of conservation of gene organization among mammalian species.
